PCMTD1
Protein-L-isoaspartate O-methyltransferase domain-containing protein 1
Also known as: FLJ10883, PCMD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96MG8
- Gene
- PCMTD1
- Ensembl
- ENSG00000168300
- Chromosome
- 8
- Canonical length
- 357 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
Enables ubiquitin-like ligase-substrate adaptor activity. Involved in protein ubiquitination. Part of Cul5-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
357 residues, UniProt reviewed canonical sequence.
>Q96MG8|PCMTD1
1 MGGAVSAGED NDDLIDNLKE AQYIRTERVE QAFRAIDRGD YYLEGYRDNA YKDLAWKHGN
61 IHLSAPCIYS EVMEALKLQP GLSFLNLGSG TGYLSTMVGL ILGPFGINHG IELHSDVVEY
121 AKEKLESFIK NSDSFDKFEF CEPAFVVGNC LQIASDSHQY DRIYCGAGVQ KDHENYMKIL
181 LKVGGILVMP IEDQLTQIMR TGQNTWESKN ILAVSFAPLV QPSKNDNGKP DSVGLPPCAV
241 RNLQDLARIY IRRTLRNFIN DEMQAKGIPQ RAPPKRKRKR VKQRINTYVF VGNQLIPQPL
301 DSEEDEKMEE DNKEEEEKDH NEAMKPEEPP QNLLREKIMK LPLPESLKAY LTYFRDKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCMTD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 78 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 78 nTPM
- parathyroid gland: 73 nTPM
- pancreas: 66 nTPM
- tongue: 63 nTPM
- salivary gland: 54 nTPM
- thyroid gland: 50 nTPM
Single-cell type
- neutrophils: 603 nCPM
- myonuclei: 567 nCPM
- neutrophil progenitors: 404 nCPM
- platelets: 376 nCPM
- pancreatic acinar cells: 332 nCPM
- podocytes: 331 nCPM
Immune cell
- neutrophil: 30 nTPM
- eosinophil: 23 nTPM
- NK-cell: 22 nTPM
- basophil: 19 nTPM
- plasmacytoid DC: 15 nTPM
- naive CD4 T-cell: 14 nTPM
Brain region
- cerebellum: 45 nTPM
- choroid plexus: 41 nTPM
- white matter: 36 nTPM
- hypothalamus: 34 nTPM
- basal ganglia: 34 nTPM
- pons: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.27
- gnomAD missense Z
- 2.61
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- protein-L-isoaspartate (D-aspartate) O-methyltransferase activity
- ubiquitin-like ligase-substrate adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCMTD1 as an antibody target. Whether an autoantibody or antibody against PCMTD1 could matter depends on whether native PCMTD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCMTD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCMTD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...